Cholesterol oxidation products induce vascular foam cell lesion formation in hypercholesterolemic New Zealand White rabbits

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 19, Issue 9, 1999, Pages 2179-2188

  Rong, James X ^a   Shen, Lijiang ^b   Chang, Yi H ^b   Richters, Arnis ^a   Hodis, Howard N ^b,c   Sevanian, Alex ^a,b,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Cholesterol feeding; Foam cell lesions; Hypercholesterolemia; Oxysterols

Indexed keywords

CHOLESTEROL; CHOLESTEROL DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CELL DAMAGE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL INTAKE; CONTROLLED STUDY; FOAM CELL; HYPERCHOLESTEROLEMIA; MALE; NONHUMAN; OXIDATION; PRIORITY JOURNAL;

EID: 0032877556     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.19.9.2179     Document Type: Article

References (70)

1. Smith LL. Review of progress in sterol oxidations: 1987-1995. Lipids. 1996;31:453-487.
2. Sevanian A, Peterson AR. The cytotoxic and mutagenic properties of cholesterol oxidation products. Food Chem Toxicol. 1986;24:1103-1110.
3. Sevanian A, Berliner J, Peterson H. Uptake, metabolism and cytotoxicity of isomeric cholesterol-5,6-epoxides in rabbit aortic endothelial cells. J Lipid Res. 1991;32:147-155.
4. Sevanian A, Hodis HN, Hwang J, Peterson H. Involvement of cholesterol oxides in the atherogenic action of oxidized LDL. In: Bellomo G, Finardi G, Maggi E, Rice-Evans C, eds. Free Radicals, Lipoprotein Oxidation and Atherosclerosis. 1st ed. London, England: Eichelieu Press; 1995: 139-161.
5. Palladini G, Finardi G, Bellomo G. Disruption of actin microfilament organization by cholesterol oxides in 73/73 endothelial cells. Exp Cell Res. 1996;223:72-82.
6. Peng SK, Tham P, Taylor CB, Mikkelson B. Cytotoxicity of oxidation derivatives of cholesterol on cultured aortic smooth muscle cells and their effect on cholesterol biosynthesis. Am J Clin Nutr. 1979;32:1033-1042.
7. Hughes H, Mathews B, Lenz ML, Guyton JR. Cytotoxicity of oxidized LDL to porcine aortic smooth muscle cells is associated with the oxysterols 7-ketocholesterol and 7-hydroxycholesterol. Arterioscler Thromb. 1994;14:1177-1185.
8. Nishio E, Watanabe Y. Oxysterols induced apoptosis in cultured smooth muscle cells through CPP32 protease activation and bcl-2 protein down-regulation. Biochem Biophys Res Commun. 1996;226:928-934.
9. Boissonneault GA, Hennig B, Wang Y, Ouyang CM, Krahulik K, Cunnup L, Oeltgen PR. Effect of oxysterol-enriched low-density lipoprotein on endothelial barrier function in culture: low-density lipoproteins. Ann Nutr Metab. 1991;35:226-232.
10. Boissonneault GA, Hennig B, Ouyang CM. Oxysterols, cholesterol biosynthesis, and vascular endothelial cell monolayer barrier function. Proc Soc Exp Biol Med. 1991;196:338-343.
11. Deckert V, Brunet A, Lantoine F, Lizard G, Brussel EM, Monier S, Lagrost L, David-Dufilho M, Gamber P, Devynck M-A. Inhibition by cholesterol oxides of NO release from human vascular endothelial cells. Arterioscler Thromb Vasc Biol. 1998;18:1054-1060.
12. Deckert V, Persegol L, Viens L, Lizard G, Athias A, Lallemant C, Gambert P, Lagrost L. Inhibitors of arterial relaxation among components of human oxidized low-density lipoproteins: cholesterol derivatives oxidized in position 7 are potent inhibitors of endothelium-dependent relaxation. Circulation. 1997;95:723-731.
13. Tamasawa N, Hayakari M, Murakami H, Matsui J, Toshihiro S. Reduction of oxysterol levels up-regulates HMG-CoA reductase activity in rat liver. Atherosclerosis. 1997;131:237-242.
14. Taylor FR, Kandutsch AA. Use of oxygenated sterols to probe the regulation of 3-hydroxy-3-methylglutaryl-CoA reductase and sterologenesis. Methods Enzymol. 1985;110:9-19.
15. Kilsdonk EPC, Morel DW, Johnson WJ, Rothblat GH. Inhibition of cellular cholesterol efflux by 25-hydroxycholesterol. J Lipid Res. 1995; 36:505-516.
16. Fielding CJ, Bist A, Fielding PE. Caveolin mRNA levels are up-regulated by free cholesterol and down-regulated by oxysterols in fibroblast monolayers. Proc Natl Acad Sci U S A. 1997;94:3753-3758.
17. Gelissen IC, Brown AJ, Mander EL, Kritharides L, Dean RT, Jessup W. Sterol efflux is impaired from macrophage foam cells selectively enriched with 7-ketocholesterol. J Biol Chem. 1996;271:17852-17860.
18. Cheng D, Chang CCY, Qu X-M, Chang T-Y. Activation of acylcoenzyme A:cholesterol acyltransferase by cholesterol or by oxysterol in a cell-free system. J Biol Chem. 1995;270:685-695.
19. Brown MS, Dana SE, Goldstein JL. Cholesterol ester formation in cultured human fibroblasts: stimulation by oxygenated sterols. J Biol Chem. 1975;250:4025-4027.
20. Hodis HN, Kramsch DM, Avogaro P, Bittolo-Bon G, Cazzolato G, Hwang J, Peterson H, Sevanian A. Biochemical and cytotoxic characteristics of an in vivo circulating oxidized LDL. J Lipid Res. 1994;35: 669-677.
21. Hodis HN, Crawford DW, Sevanian A. Cholesterol feeding increases plasma and aortic tissue cholesterol oxide levels in parallel: further evidence for the role of cholesterol oxidation in atherosclerosis. Atherosclerosis. 1991;89:117-126.
22. Hodis HN, Chauhan A, Hashimoto S, Crawford DW, Sevanian A. Probucol reduces plasma and aortic wall oxysterol levels in cholesterol fed rabbits independently of its plasma cholesterol lowering effect. Atherosclerosis. 1992;96:125-134.
23. Mahfouz MM, Kawano H, Kummerow FA. Effect of cholesterol-rich diets with and without added vitamins E and C on the severity of atherosclerosis in rabbits. Am J Clin Nutr. 1997;66:1240-1249.
24. Staprans I, Pan X-M, Rapp JH, Feingold KR. Oxidized cholesterol in the diet accelerates the development of aortic atherosclerosis in cholesterol-fed rabbits. Arterioscler Thromb Vasc Biol. 1998;18:977-983.
25. Rong JX, Rangaswamy S, Shen L, Dave R, Chang YH, Hazel P, Hodis HN, Chisolm GM, Sevanian A. Arterial injury by cholesterol oxidation products causes endothelial dysfunction and arterial wall cholesterol accumulation. Arterioscler Thromb Vasc Biol. 1998;18:1885-1894.
26. Sevanian A, Bittolo-Bon G, Cazzolato G, Hodis H, Hwang J, Zamburlini A, Maiorino M, Ursini F. LDL- is a lipid hydroperoxide-enriched circulating lipoprotein. J Lipid Res. 1997;38:419-428.
27. Clarkson TB, Lehner NDM, Bullock BC. Specialized research applications, I: arteriosclerosis research. In: Weisbroth SH, Flatt RE, Kraus AL, eds. The Biology of the Laboratory Rabbit. 5th ed. San Diego, Calif: Academic Press Inc; 1993:155-164.
28. Parker F, Peterson N, Odland GF. A comparison of cholesterol-ester fatty acid patterns in the blood and in evolving xanthoma and atheroma during cholesterol-feeding of rabbits. J Invest Dermatol. 1966;47:253-259.
29. Newman HAI, Zilversmit DB. Accumulation of lipid and nonlipid constituents in rabbit atheroma. J Atheroscler Res. 1964;4:261-271.
30. Jokinen MP, Clarkson TB, Prichard RW. Recent advances in molecular pathology: animal models in atherosclerosis research. Exp Mol Pathol. 1985;42:1-28.
31. Evan AS, Myers GL. Lipids, lipoproteins, and apolipoproteins. In: Burtis CA, Ashwood ER, eds. Tietz Textbook of Clinical Chemistry. 2nd ed. Philadelphia, Pa: WB Saunders Co; 1994:1002-1093.
32. Holvoet P, Collen D. β-VLDL hypercholesterolemia relative to LDL hypercholesterolemia is associated with higher levels of oxidized lipoproteins and a more rapid progression of coronary atherosclerosis in rabbits. Arterioscler Thromb Vasc Biol. 1997;17:2376-2382.
33. Adams CWM, Miller NE, Morgan RS, Rao SN. Lipoprotein levels and tissue lipids in fatty-fibrous atherosclerosis induced in rabbits by two years' cholesterol feeding at a low level. Atherosclerosis. 1982;44:1-8.
34. Feldman DL, Mogelesky TC, Liptak BF, Gerrity RG. Leukocytosis in rabbits with diet-induced atherosclerosis. Arterioscler Thromb. 1991;11: 985-994.
35. Daley SJ, Klemp KF, Guyton JR, Rogers KA. Cholesterol-fed and casein-fed rabbit models of atherosclerosis, part 2: differing morphological severity of atherogenesis despite matched plasma cholesterol levels. Arterioscler Thromb. 1994;14:105-114.
36. Bocan TMA, Mueller SB, Uhlendorf PD, Newton RS, Krause BR. Comparison of CI-976, an ACAT inhibitor, and selected lipid-lowering agents for antiatherosclerotic activity in iliac-femoral and thoracic aortic lesions: a biochemical, morphological, and morphometric evaluation. Arterioscler Thromb. 1991;11:1830-1843.
37. Bocan TMA, Mueller SB, Mazur MJ, Uhlendorf PD, Brown EQ, Kieft KA. The relationship between the degree of dietary-induced hypercholesterolemia in the rabbit and atherosclerotic lesion formation. Atherosclerosis. 1993;102:9-22.
38. Daley SJ, Herderick EE, Cornhill JF, Rogers KA. Cholesterol-fed and casein-fed rabbit models of atherosclerosis, part 1 : differing lesion area and volume despite equal plasma cholesterol levels. Arterioscler Thromb. 1994;14:95-104.
39. Kolodgie FD, Katocs AS, Largis EE, Wrenn SM, Cornhill JF, Herderick EE, Lee SJ, Virmani R. Hypercholesterolemia in the rabbit induced by feeding graded amounts of low-level cholesterol: methodological considerations regarding individual variability in response to dietary cholesterol and development of lesion type. Arterioscler Thromb Vasc Biol. 1996; 16:1454-1464.
40. Institute of Laboratory Animal Resources, National Research Council. Guide for the Care and Use of Laboratory Animals. 7th ed. Washington, DC: National Academy Press; National Institutes of Health, Dept of Agriculture and Dept of Human Affairs. 1996.
41. Lipid Research Clinics Program: The Manual of Laboratory Operations: Lipid and Lipoprotein Analysis. Bethesda. Md: National Institutes of Health; Dept of Health, Education and Welfare publication. 1974.
42. Karpe F, Hamsten A. Determination of apolipoproteins B-48 and B-100 in triglyceride-rich lipoproteins by analytical SDS-PAGE. J Lipid Res. 1994;35:1311-1317.
43. Mero N, Syvanne M, Rosseneu M, Labeur C, Hilden H, Taskinen M-R. Comparison of three fatty meals in healthy normolipidaemic men: high post-prandial retinyl ester response to soybean oil. Eur J Clin Invest. 1998;28:407-415.
44. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol. 1959;37:911-917.
45. Kaluzny MA, Duncan LA, Merritt MV, Epps DE. Rapid separation of lipid classes in high yield and purity using bonded phase columns. J Lipid Res. 1985;26:135-144.
46. Tsukada T, Rosenfeld M, Ross R, Gown AM. Immunocytochemical analysis of cellular components in atherosclerotic lesions: use of monoclonal antibodies with the Watanabe and fat-fed rabbit. Arteriosclerosis. 1986;16:601-613.
47. Watabe T, Isobe M, Kanai M. Cholesterol diet increases plasma and liver concentrations of cholesterol epoxides and cholestanetriol. J Pharmacobiodyn. 1980;3:553-556.
48. Vine DF, Croft KD, Beilin LJ, Mamo JCL. Absorption of dietary cholesterol oxidation products and incorporation into rat lymph chylomicrons. Lipids. 1997;32:887-893.
49. Krut LH, Yang JW, Schonfeld G, Ostlund REJ. The effect of oxidizing cholesterol on gastrointestinal absorption, plasma clearance, tissue distribution, and processing by endothelial cells. Arterioscler Thromb Vasc Biol. 1997;17:778-785.
50. Osada K, Sasaki E, Sugano M. Lymphatic absorption of oxidized cholesterol in rats. Lipids. 1994;29:555-559.
51. Kaur M, Kaur J, Ojha S, Mahmood A. Ethanol effects on lipid peroxidation and glutathione-mediated defense in rat small intestine: role of dietary fats. Alcohol. 1998;15:65-69.
52. Smith LL. The oxidation of cholesterol. In: Peng S-K, Morin RJ, eds. Biological Effects of Cholesterol Oxides. Boca Raton, Fla: CRC Press Inc; 1992:7-31.
53. Staprans I, Rapp JH, Pan XM, Feingold KR. Oxidized lipids in the diet are incorporated by the liver into very low density lipoprotein in rats. J Lipid Res. 1996;37:420-430.
54. Cook RP, MacDougall JDB. Experimental atherosclerosis in rabbits after feeding cholestane triol. Br J Exp Pathol. 1968;49:265-271.
55. Matthias D, Becher C-H, Godicke W, Schmidt R, Ponsold K. Action of cholestane-3β,5α,6β-triol on rats with particular reference to the aorta. Atherosclerosis. 1987;63:115-124.
56. Jacobson MS, Price MG, Shamoo AE, Heald FP. Atherogenesis in white Carneau pigeons: effects of low-level cholestane-triol feeding. Atherosclerosis. 1985;57:209-217.
57. Imai H, Werthessen NT, Subramanyam V, Lequosne PW, Soloway AH, Kanisawa M. Angiotoxicity of oxygenated sterols and possible precursors. Science. 1980;207:651-653.
58. Higley NA, Beery JT, Taylor SL, Porter JW, Dziuba JW, Lalich JJ. Comparative atherogenic effects of cholesterol and cholesterol oxides. Atherosclerosis. 1986;62:91-104.
59. Smith LL. Cholesterol autoxidation 1981-1986. Chem Phys Lipids. 1987; 44:87-125.
60. Peng SK, Hu B, Morin RJ. Angiotoxicity and atherogenicity of cholesterol oxides. J Clin Lab Anal. 1991;5:144-152.
61. Hulten LM, Lindmark H, Diczfalusy U, Bjorkhem I, Ottosson M, Liu Y, Bondjers G, Wiklund O. Oxysterols present in atherosclerotic tissue decrease the expression of lipoprotein lipase messenger RNA in human monocyte-derived macrophages. J Clin Invest. 1996;97:461-468.
62. Hennig B, Boissonneault GA. Cholestane-3β,5α,6β-triol decrease barrier function of cultured endothelial cell monolayers. Atherosclerosis. 1987; 63:115-124.
63. Ramasamy S, Boissonneault GA, Hennig B. Oxysterol-induced endothelial cell dysfunction in culture. J Am Coll Nutr. 1992;11:532-538.
64. Chang CC, Jone C, Trosko JE, Peterson AR, Sevanian A. Effect of cholesterol epoxides on the inhibition of intercellular communication and on mutation induction in Chinese hamster V79 cells. Mut Res. 1988;206: 471-478.
65. Davies PF, Selden SC, Schwartz SM. Enhanced rates of fluid pinocytosis during exponential growth and monolayer regeneration by cultured arterial endothelial cells. J Cell Physiol. 1980;102:119-127.
66. Lin SJ, Jan KM, Weinbaum S, Chien S. Transendothelial transport of low density lipoprotein in association with cell mitosis in rat aorta. Arteriosclerosis. 1989;9:230-236.
67. Cao J, Fales HM, Schaffner CP. Cellular sterol accumulation stimulated by cholesterol 5β,6β-epoxide in J774 macrophages (43896). Proc Soc Exp Biol Med. 1995;209:195-204.
68. St Clair RW. Cholesterol ester metabolism in atherosclerotic arterial tissue. Ann N Y Acad Sci. 1976;275:228-237.
69. Hoppe G, Ravandi A, Herrera D, Kuksis A, Hoff HF. Oxidation products of cholesteryl linoleate are resistant to hydrolysis in macrophages, form complexes with proteins, and are present in human atherosclerotic lesions. J Lipid Res. 1997;38:1347-1360.
70. Hoff HF, Hoppe G. Structure of cholesterol-containing particles accumulating in atherosclerotic lesions and the mechanisms of their derivation. Curr Opin Lipidol. 1995;6:317-325.